Bayer stock has its best day in 17 years after support from Trump's solicitor general

Core Viewpoint - Bayer shares experienced a significant increase of up to 15% following the support from the U.S. solicitor general for the company's request to limit litigation related to its Roundup pesticide and its alleged link to cancer [1] Company Summary - Bayer's stock performance improved notably, reflecting investor confidence after the U.S. solicitor general's backing [1] - The legal challenges surrounding Roundup have been a major concern for Bayer, and the potential curtailment of these lawsuits could positively impact the company's financial outlook [1]